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Inhibition of Mononuclear Cell Procoagulant Activity 
by Lipophosphoglycan of Leishmania donowuni 
Raffaele Del Prete, Maria Raffaella Buongiorno, Adriana Mosca, 
and Giuseppe Miragliotta 
Background: Since fibrin formation is an expression of the response of the host to parasite spread, the lipo- 
phosphoglycan (LPG) of Leishmania donovani and its carbohydrate fragment (PG) were examined for their capacity to 
inhibit procoagulant activity (PCA) production by human mononuclear cells stimulated with Escherichia coli endotoxin 
in vitro. 
Methods: the putative inhibitory effect of LPG and its PG fragment was evaluated on the basis of their in vitro capacity 
to prolong significantly the time required for coagulation induced by endotoxin-stimulated mononuclear cells. 
Results: LPG exhibited the most inhibitory activity, whereas the carbohydrate domain was not effective. These results 
are in agreement with the notion that LPG (but not PG) has an inhibitory effect on protein kinase C activity which plays 
a key role in the production of PCA by human monocytes. 
Conclusions: From a pathophysiological point of view, these data suggest the possibility that Leishmania avoids fibrin 
entrapment in the host through this inhibitory mechanism. 
introduction 
The protozoan parasite Leishmania donovani is the 
causative agent of the often life-threatening disease 
kala-azar. This organism survives in the host as an 
amastigote within circulating macrophages which are 
regularly infected after the bite of a blood-sucking 
sandfly vector (1). However, because of the relatively 
poor knowledge of the parasite’s cell biology, still 
fragmentary information is available about how the 
parasite avoids destruction in the host’s environment. It 
appears likely that the capacity of L. donovani to persist 
in both vector and host may be related to the presence 
of highly specialized molecules on the parasite’s cell 
surface. The recently identified major surface molecule 
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lipophosphoglycan (LPG) appears to be the candidate 
to play this important role in the host cell-parasite 
interaction (2, 3,  4). LPG is a heterogeneous glyco- 
conjugate containing, as its salient feature, a repeating 
phosphorylated disac-charide unit. The repeated units 
are attached to an unusual lysoalkylphosphatidylinositol 
lipid anchor via a phosphoheptasaccharide carbo- 
hydrate core ( 5 ,  6, 7).  O n  the other hand, human 
mononuclear cells (i.e. monocytes and lymphocytes) 
produce a potent tissue factor-like procoagulant activity 
(PCA) in response to several stimuli, including the 
endotoxin of gram-negative bacteria (lipoplysaccharide 
or LPS) (8). In turn, this tissue factor-like procoagulant 
activity activates the clotting cascade through the 
extrinsic pathway of blood coagulation with formation 
of fibrin (9). Since fibrin formation is an expression of 
the response of the host, procoagulant activity pro- 
duction can be regarded as an important function of the 
immune response (10). 
O n  this basis, we have examined in our in vitro 
experiments the putative ability of L. donovani LPG and 
of its carbohydrate portion (PG) to inhibit the PCA 
production by LPS-stimulated human mononuclear 
cells and we suggest herein the importance of LPG for 
both survival and spread of the parasite. 
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Materials and Methods 
Lipopolysaccharide (LPS) endotoxin 
Escherichia coli LPS 0125:B8 was purchased from 
DIFCO Laboratories, Detroit Michigan, USA. 
Lipophosphoglycan (LPGI 
LPG was isolated from stationary phase cultures of 
L. donovani promastigotes, as described (5). The entire 
carbohydrate portion termed “phosphoglycan” (PG) 
was obtained by treatment of LPG with phosphatidy- 
linositol-specific phospholipase C (1 1). Either LPG or 
PG were resuspended in sterile apyrogen saline and 
sonicated for 60 seconds before use. Suspensions were 
tested by Limulus amebocyte lysate assay (Whitaker 
Bioproducts, Walkersville, MD) in order to ascertain 
the absence of endotoxin. 
Blood collection and preparation of mononuclear cells 
Blood was collected from healthy donors using 
trisodium citrate (0.015 M final concentration) as the 
anticoagulant. According to the method ofBoyum (12), 
mononuclear cells were isolated with the LeucosepTM 
device (Opopharma AG, Zurich, Switzerland) using 
Lymphoprep (Nycomed Fharma AS, Oslo, Norway) as 
a separation medium. The cells were washed three 
times with citrated Hanks’ balanced salt solution 
(HBSS) and then resuspended in HBSS without citrate 
at  the desired concentration. Granulocyte contami- 
nation was less than 5% and the ratio of platelets 
to leukocytes was less than 1:l as determined by 
light microscopy. Twenty percent of these cells were 
identified as monocytes by cytochemical reactivity 
for a-naphtyl-acetate esterase (13). The suspensions of 
mononuclear cells were incubated with E. coli LPS 
(0.2pM final concentration), L. donovani LPG (0.2 pM 
final concentration), and E. coli LPS (0.2 pM final 
concentration) along with LPG at different concen- 
trations (0.4 pM, 1 pM, 2 pM, 4 pM). The negative 
control was represented by mononuclear cells in- 
cubated with apyrogen saline. In order to investigate the 
role played by the carbohydrate portion, another set of 
experiments was carried out using PG instead of LPG 
in the incubation mixtures. 
Procoagulant assay 
After a 4-hour incubation at 37OC, PCA was evaluated 
by a one-stage plasma recalcification time. Citrated 
human plasma (pooled from at least three healthy 
donors) was used as a substrate. Clotting time was 
determined in duplicate in plastic tubes using a manual 
method on a mixture of 0.1 ml plasma, 0.1 ml cell 
suspension, 0.1 ml 0.025 M CaC12 (14). 
When L. donovani -LPG or -PG was added to the 
E. coli LPS-mononuclear cells incubation mixtures, the 
percent PCA inhibition was derived from the assays 
described above using the formula (B - A)/A x 100 
where A represents the time to clotting induced by E.  
coli LPS and B the time to clotting induced by E. coli 
LPS along with LPG or PG. 
Statistics 
Data are expressed as means 5 SEM. 
Results 
Our experimental approach consisted in determining 
the effect of exogenous LPG or its entire carbohydrate 
fragment on coagulation time. Table 1 clearly shows 
that the addition of L. donovani LPG but not L. donovani 
PG (2pM final concentration) to human mononuclear 
cells incubated with E. coli LPS significantly inhibits 
their capacity to shorten the clotting time of normal 
plasma. The inhibition is dose-dependent (Figure 1). 
At higher concentrations of LPG (i.e. 2 pM, and 4 
pM) clotting does not occur in the test tube after 
incubation of mononuclear cells with endotoxin 
(clotting time >360 seconds, 100% inhibition). 
Furthermore, in Figure 1 it is also shown that when the 
delipidated carbohydrate portion of LPG (PG) was 
added to the incubation mixtures, no inhibitory 
effect on PCA production was observed at the four 
concentrations tested. 
Table 1 Effect of Leishmania donovani -LPG and -PG on 
the PCA production by mononuclear cells stimulated with 
Escherichia coli LPS. 
Mononuclear cells No .f Clotting time % inhibition 
incubated with experiments (sectSEM) 
E. coli LPS (0.2 Fm) 4 87.62?1.9 
L. donovani LPG (2 pm) 4 >360 
L. donovani PG (2 pm) 4 264.66?21.0 
E. coli LPS (0.2 Fm) + 
L. donouani LPG (2 pm) 4 2360 
E. coli LPS (0.2 wm) + 
L. donovani LPG (2 pm) 4 74.6626.0 
100 
Saline 4 >360 
Discussion 
Both the attachment and entry of L. donovani into 
the host cell are crucial for the microorganism to 
infect mononuclear cells. In this regard, LPG has 
been demonstrated to play a role in promoting the 
attachment of promastigotes to macrophages via C3 
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Figure 1 Dose-dependence of the inhibitory effect of 
Leishmania donovani LPG on procoagulant activity pro- 
duction by human mononuclear cells stimulated with 
Escherichia coli endotoxin. 
receptors. LPG can indeed activate complement 
with resulting C3 deposition on the surface of the 
parasite (15). In our experiments, we have demon- 
strated that LPG possesses another activity, namely 
that of strongly inhibiting the in vitro production of 
PCA by endotoxin-stimulated human mononuclear 
cells. Through the extrinsic pathway of blood 
coagulation, PCA in turn promotes fibrin formation. 
This deposition of fibrin represents an important step 
in the aspecific defense mechanism since it contributes 
to the entrapment of the parasite. If entrapped within 
a network of fibrin, Leishmania cannot attach to 
monocytes and cannot be internalyzed in the phago- 
lysosomal system where it is protected from 
phagocytosis by reticulo-endothelial cells and from 
antimicrobial factors in the plasma if the infected 
circulating cells remain healthy. The mechanism of 
survival of Leishmania within the macrophage has 
been clarified by the demonstration of the LPG 
capacity to inhibit the activation of protein kinase C 
(PKC) in vitro (16). PKC is involved in the induction 
of the oxidative burst (17) and the phagocytosis of 
LPG-coated beads has been demonstrated to suppress 
the induction of the respiratory burst in mono- 
cytes (18). O n  the other hand the evidence that 
endotoxin-induced PCA production by monocytes is 
dependent upon PKC activation (19) suggests that the 
molecular mechanism responsible for the inhibitory 
effect on PCA by LPG might be PKC suppression. 
Furthermore, in our experiments the failure of the 
delipidated carbohydrate portion (i.e. phosphoglycan, 
PG) to inhibit PCA production is in agreement with 
the notion that it is the lipid domain and not the 
carbohydrate portion of LPG which is primarily 
responsible for suppression of PKC activity (20). Taken 
together our results suggest that LPG of L. donovani 
contributes to protect the parasite from fibrin 
entrapment. 
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